Home Cart 0 Sign in  
X

[ CAS No. 1780-17-2 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 1780-17-2
Chemical Structure| 1780-17-2
Chemical Structure| 1780-17-2
Structure of 1780-17-2 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1780-17-2 ]

Related Doc. of [ 1780-17-2 ]

Alternatived Products of [ 1780-17-2 ]

Product Details of [ 1780-17-2 ]

CAS No. :1780-17-2 MDL No. :MFCD00086626
Formula : C10H9NO Boiling Point : -
Linear Structure Formula :- InChI Key :HREHOXSRYOZKNT-UHFFFAOYSA-N
M.W : 159.18 Pubchem ID :73196
Synonyms :

Calculated chemistry of [ 1780-17-2 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 10
Fraction Csp3 : 0.1
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 47.87
TPSA : 33.12 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.32 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.81
Log Po/w (XLOGP3) : 1.34
Log Po/w (WLOGP) : 1.58
Log Po/w (MLOGP) : 1.22
Log Po/w (SILICOS-IT) : 2.31
Consensus Log Po/w : 1.65

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.22
Solubility : 0.955 mg/ml ; 0.006 mol/l
Class : Soluble
Log S (Ali) : -1.64
Solubility : 3.67 mg/ml ; 0.0231 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -3.52
Solubility : 0.0483 mg/ml ; 0.000303 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.22

Safety of [ 1780-17-2 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338-P310 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1780-17-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1780-17-2 ]
  • Downstream synthetic route of [ 1780-17-2 ]

[ 1780-17-2 ] Synthesis Path-Upstream   1~26

  • 1
  • [ 19575-07-6 ]
  • [ 1780-17-2 ]
YieldReaction ConditionsOperation in experiment
73% With sodium tetrahydroborate In tetrahydrofuran at 20 - 35℃; for 0.5 h; Methyl quinoline 2-carboxylate 2 (5 g, 26.8 mmol) in solution in THF (30 mL) was added, at room temperature, to a solution of NaBH4 (710 mg, 18.8 mmol) in THF (20 mL). The mixture was stirred at 35 °C for 30 min. Then, at 35 °C, methanol (2.5 mL) was added followed by warm water (30 mL), and finally ethyl acetate (20mL). The organic layer was washed with water (2×30 mL). The organic phase was dried over magnesium sulfate, filtered, and concentrated under reduced pressure. The crude yellow-blue residue was purified through a silica gel column chromatography (AcOEt/MCH: 60/40). White solid; 73percent yield; mp 135 °C (dec); 1H NMR (300 MHz, CDCl3) 4.68 (1H, s, OH), 4.95 (2H, s, CH2), 7.31 (1H, m, CHar), 7.55 (1H, m, CHar), 7.71 (1H, m, CHar), 7.81 (1H, m, CHar), 8.10 (2H, m, CHar); 13C NMR (75 MHz, CDCl3) 64.25, 118.43, 126.35, 127.55, 127.69, 128.57, 129.81, 136.86, 146.72, 159.19; Anal. Calcd. for C10H9NO C, 75.45; H, 5.70; N, 8.80. Found C, 75.13; H, 5.56; N, 8.75.
Reference: [1] Organic Letters, 2005, vol. 7, # 17, p. 3609 - 3612
[2] Tetrahedron Letters, 2012, vol. 53, # 35, p. 4747 - 4750
[3] Tetrahedron, 2013, vol. 69, # 44, p. 9322 - 9328
[4] Tetrahedron Asymmetry, 2009, vol. 20, # 14, p. 1672 - 1682
[5] Journal of Organic Chemistry, 1953, vol. 18, p. 55,56
  • 2
  • [ 5470-96-2 ]
  • [ 1780-17-2 ]
YieldReaction ConditionsOperation in experiment
85%
Stage #1: With sodium tetrahydroborate In methanol for 0.333333 h;
Stage #2: With water In methanol
Example 16 2-(2,6-Dioxo-piperidin-3-yl)-4-(quinolin-2-ylmethoxy)-isoindole-l,3-dioneStep 1 :[207] 2-Quinolinecarbaldehyde (2.00 g, 12.7 mmol) was dissolved in 25 mL of methanol. To this solution was added sodium borohydride (0.24 g, 6.4 mmol) in small portions over a period of 20 minutes. Then 2 mL of water were added and the mixture was evaporated. The residue was dissolved in ethyl acetate (75 mL) and washed with water (3 x 75 mL) and evaporated. The residue was chromatographed in CH2Cl2-methanol gradient, eluting the product at 97:3 CH2Cl2-methanol, and providing 1.7 g of quinolin-2-yl-methanol in 85percent yield; 1H NMR (CDCl3) δ 4.92 (s, 2H), 7.26 (d, J = 2.1 Hz, IH), 7.30-7.57 (m, IH), <n="68"/>7.68-7.75 (m, IH), 7.82 (dd, J = 8.0 Hz, J = 0.9 Hz, IH), 8.07 (d, J = 8.4 Hz, IH), 8.13 (d, J = 8.5 Hz, IH).
Reference: [1] Tetrahedron, 1999, vol. 55, # 41, p. 12069 - 12078
[2] Tetrahedron Letters, 2013, vol. 54, # 38, p. 5211 - 5213
[3] Chemistry - An Asian Journal, 2017, vol. 12, # 2, p. 239 - 247
[4] Patent: WO2008/115516, 2008, A2, . Location in patent: Page/Page column 66-67
[5] ChemCatChem, 2015, vol. 7, # 8, p. 1292 - 1301
[6] Archiv der Pharmazie (Weinheim, Germany), 1959, vol. 292, p. 682,690
[7] Archiv der Pharmazie (Weinheim, Germany), 1959, vol. 292, p. 682,690
[8] Patent: US2003/229026, 2003, A1, . Location in patent: Page 27-28
[9] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 15, p. 4364 - 4374
[10] Patent: US9321730, 2016, B2, . Location in patent: Page/Page column 14
  • 3
  • [ 60483-07-0 ]
  • [ 1780-17-2 ]
Reference: [1] Yakugaku Zasshi, 1954, vol. 74, p. 790[2] Chem.Abstr., 1955, p. 11646
[3] Journal of the American Chemical Society, 1954, vol. 76, p. 1286,1289
[4] Patent: EP1228067, 2004, B1, . Location in patent: Page 67
  • 4
  • [ 61831-29-6 ]
  • [ 1780-17-2 ]
Reference: [1] Synlett, 2008, # 4, p. 543 - 546
[2] Chemische Berichte, 1936, vol. 69, p. 534
  • 5
  • [ 1076-28-4 ]
  • [ 1780-17-2 ]
Reference: [1] Journal of Organometallic Chemistry, 2008, vol. 693, # 18, p. 3063 - 3073
[2] Chemische Berichte, 1936, vol. 69, p. 534
[3] Yakugaku Zasshi, 1958, vol. 78, p. 608,610[4] Chem.Abstr., 1958, p. 18420
  • 6
  • [ 91-63-4 ]
  • [ 1780-17-2 ]
Reference: [1] Journal of the American Chemical Society, 1954, vol. 76, p. 1286,1289
[2] Tetrahedron Letters, 2013, vol. 54, # 38, p. 5211 - 5213
[3] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 15, p. 4364 - 4374
  • 7
  • [ 63430-96-6 ]
  • [ 1780-17-2 ]
Reference: [1] Angewandte Chemie - International Edition, 2013, vol. 52, # 27, p. 6983 - 6987[2] Ross. Khim. Zh., 2013, vol. 125, # 27, p. 7121 - 7125,5
  • 8
  • [ 163733-96-8 ]
  • [ 1780-17-2 ]
Reference: [1] Patent: US2003/4150, 2003, A1,
[2] Patent: US6815546, 2004, B2,
  • 9
  • [ 235-21-2 ]
  • [ 1780-17-2 ]
Reference: [1] Journal of Chemical Research, Miniprint, 1984, # 5, p. 1430 - 1440
[2] Journal of Chemical Research, Miniprint, 1984, # 5, p. 1430 - 1440
  • 10
  • [ 93-10-7 ]
  • [ 1780-17-2 ]
Reference: [1] Organic Letters, 2005, vol. 7, # 17, p. 3609 - 3612
  • 11
  • [ 91850-85-0 ]
  • [ 1780-17-2 ]
Reference: [1] Journal of Chemical Research, Miniprint, 1984, # 5, p. 1430 - 1440
[2] Journal of Chemical Research, Miniprint, 1984, # 5, p. 1430 - 1440
  • 12
  • [ 3240-34-4 ]
  • [ 65094-35-1 ]
  • [ 1780-17-2 ]
  • [ 60483-07-0 ]
Reference: [1] Heterocycles, 1996, vol. 43, # 6, p. 1151 - 1158
  • 13
  • [ 76253-74-2 ]
  • [ 1780-17-2 ]
Reference: [1] Pharmazie, 1982, vol. 37, # 5, p. 344 - 349
[2] Pharmazie, 1982, vol. 37, # 5, p. 344 - 349
  • 14
  • [ 3747-74-8 ]
  • [ 1780-17-2 ]
Reference: [1] Pharmazie, 1982, vol. 37, # 5, p. 344 - 349
[2] Pharmazie, 1982, vol. 37, # 5, p. 344 - 349
  • 15
  • [ 91850-86-1 ]
  • [ 1780-17-2 ]
Reference: [1] Journal of Chemical Research, Miniprint, 1984, # 5, p. 1430 - 1440
[2] Journal of Chemical Research, Miniprint, 1984, # 5, p. 1430 - 1440
  • 16
  • [ 4491-33-2 ]
  • [ 1780-17-2 ]
Reference: [1] Chemische Berichte, 1952, vol. 85, p. 152,158
  • 17
  • [ 83798-34-9 ]
  • [ 1780-17-2 ]
  • [ 1701-43-5 ]
Reference: [1] Pharmazie, 1982, vol. 37, # 5, p. 344 - 349
  • 18
  • [ 63430-79-5 ]
  • [ 1780-17-2 ]
Reference: [1] Tetrahedron Letters, 2012, vol. 53, # 35, p. 4747 - 4750
  • 19
  • [ 5470-96-2 ]
  • [ 1780-17-2 ]
  • [ 93-10-7 ]
Reference: [1] Archiv der Pharmazie (Weinheim, Germany), 1959, vol. 292, p. 682,690
  • 20
  • [ 65094-35-1 ]
  • [ 1780-17-2 ]
Reference: [1] Heterocycles, 1996, vol. 43, # 6, p. 1151 - 1158
  • 21
  • [ 4377-41-7 ]
  • [ 1780-17-2 ]
Reference: [1] Yakugaku Zasshi, 1958, vol. 78, p. 608,610[2] Chem.Abstr., 1958, p. 18420
  • 22
  • [ 91-22-5 ]
  • [ 107-21-1 ]
  • [ 1780-17-2 ]
  • [ 6281-32-9 ]
Reference: [1] Synlett, 2004, # 5, p. 874 - 876
  • 23
  • [ 91-22-5 ]
  • [ 56-81-5 ]
  • [ 1780-17-2 ]
  • [ 6281-32-9 ]
Reference: [1] Synlett, 2004, # 5, p. 874 - 876
  • 24
  • [ 77934-71-5 ]
  • [ 118-90-1 ]
  • [ 1780-17-2 ]
Reference: [1] Tetrahedron Letters, 1980, vol. 21, p. 4917 - 4920
  • 25
  • [ 7647-01-0 ]
  • [ 1076-28-4 ]
  • [ 7732-18-5 ]
  • [ 108-24-7 ]
  • [ 1780-17-2 ]
Reference: [1] Yakugaku Zasshi, 1954, vol. 74, p. 790[2] Chem.Abstr., 1955, p. 11646
  • 26
  • [ 1780-17-2 ]
  • [ 5632-15-5 ]
YieldReaction ConditionsOperation in experiment
83% With phosphorus tribromide In dichloromethane at 0 - 20℃; Quinolin-2-ylmethanol 7 (6 g, 37.8 mmol) was dissolved in CH2Cl2 (60 mL). PBr3 (2.14 mL, 22.6 mmol) was carefully added at 0 °C to this solution. The mixture was allowed to return at ambient temperature and was stirred for 30 min. Water (60 mL) was then added followed by a saturated aqueous solution of K2CO3 (40 mL) to obtain a pH=8. The organic phase was washed with brine (2×30 mL), dried over magnesium sulfate, and concentrated under reduced pressure. The crude residue was purified through a silica gel column chromatography (AcOEt/MCH: 20/80). White solid; 83percent yield; mp 55 °C (dec); 1H NMR (300 MHz, DMSO) 4.86 (2H, s, CH2), 7.67 (2H, m, CHar), 7.78 (1H, m, CHar), 7.99 (2H, m, CHar), 8.40 (1H, m, CHar); 13C NMR (75 MHz, DMSO) 35.67, 122.10, 127.46, 127.54, 128.34, 129.07, 130.53, 138.37, 147.36, 157.67; HRMS (ESI) m/z calculated for C10H9NBr [M+H]+: 221.99129, found: 221.991.
68% With dibromo sulfoxide In toluene at 110℃; for 1 h; PREPARATION 302-(Bromomethyl)quinolineThe title compound of Preparation 29 (3.68 g, 23.1 mmol) was suspended in 60 ml toluene. Thionyl bromide (12.0 g, 57.8 mmol) was slowly added and the mixture was heated at 110°C for 1 h. The mixture was concentrated under reduced pressure and the residue was partitioned between water and dichloromethane. The aqueous phase was basified with potassium carbonate and extracted three times with dichloromethane. The combined organics were washed with water, brine and dried over sodium sulphate and evaporated. The residue was purified by column chromatography (ethyl acetate-hexane, 5:95) to give 3.5 g (15.8 mmol, 68percent) of the title compound as a solid. Purity 100percent.1H NMR (400 MHz, CHLOROFORM-d) δ ppm 4.72 (s, 2 H), 7.54 - 7.62 (m, 2H), 7.70 - 7.79 (m, 1 H), 7.83 (d, J=8.21 Hz, 1 H), 8.08 (d, J=8.21 Hz, 1 H),8.19 (d, J=8.60 Hz, 1 H).HPLC/MS (9 min) retention time 5.45 min.LRMS: m/z 224 (M+1).
68%
Stage #1: With dibromo sulfoxide In toluene at 110℃; for 1 h;
Stage #2: With potassium carbonate In water
The title compound of Preparation 29 (3.68 g, 23.1 mmol) was suspended in 60 ml toluene. Thionyl bromide (12.0 g, 57.8 mmol) was slowly added and the mixture was heated at 110C for 1 h. The mixture was concentrated under reduced pressure and the residue was partitioned between water and dichloromethane. The aqueous phase was basified with potassium carbonate and extracted three times with dichloromethane. The combined organics were washed with water, brine and dried over sodium sulphate and evaporated. The residue was purified by column chromatography (ethyl acetate-hexane, 5:95) to give 3.5 g (15.8 mmol, 68percent) of the title compound as a solid. Purity 100percent. 1H NMR (400 MHz, CHLOROFORM-d) δ ppm 4.72 (s, 2 H), 7.54 - 7.62 (m, 2 H), 7.70 - 7.79 (m, 1 H), 7.83 (d, J=8.21 Hz, 1 H), 8.08 (d, J=8.21 Hz, 1 H), 8.19 (d, J=8.60 Hz, 1 H). HPLC/MS (9 min) retention time 5.45 min. LRMS: m/z 224 (M+1).
Reference: [1] Tetrahedron Letters, 2013, vol. 54, # 38, p. 5211 - 5213
[2] Tetrahedron, 1999, vol. 55, # 41, p. 12069 - 12078
[3] Tetrahedron, 2013, vol. 69, # 44, p. 9322 - 9328
[4] Tetrahedron Asymmetry, 2009, vol. 20, # 14, p. 1672 - 1682
[5] Patent: WO2012/69175, 2012, A1, . Location in patent: Page/Page column 42-43
[6] Patent: EP2457900, 2012, A1, . Location in patent: Page/Page column 25; 26
[7] Tetrahedron Letters, 2012, vol. 53, # 35, p. 4747 - 4750
[8] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 15, p. 4364 - 4374
[9] Chemistry - An Asian Journal, 2017, vol. 12, # 2, p. 239 - 247
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 1780-17-2 ]

Alcohols

Chemical Structure| 26315-73-1

[ 26315-73-1 ]

Quinolin-2-ylmethanol hydrochloride

Similarity: 0.97

Chemical Structure| 24621-70-3

[ 24621-70-3 ]

(1H-Indol-2-yl)methanol

Similarity: 0.95

Chemical Structure| 78831-36-4

[ 78831-36-4 ]

(1,10-Phenanthroline-2,9-diyl)dimethanol

Similarity: 0.93

Chemical Structure| 76884-34-9

[ 76884-34-9 ]

Isoquinolin-3-ylmethanol

Similarity: 0.92

Chemical Structure| 33787-85-8

[ 33787-85-8 ]

(4-Methylquinolin-2-yl)methanol

Similarity: 0.90

Related Parent Nucleus of
[ 1780-17-2 ]

Quinolines

Chemical Structure| 26315-73-1

[ 26315-73-1 ]

Quinolin-2-ylmethanol hydrochloride

Similarity: 0.97

Chemical Structure| 33787-85-8

[ 33787-85-8 ]

(4-Methylquinolin-2-yl)methanol

Similarity: 0.90

Chemical Structure| 108166-02-5

[ 108166-02-5 ]

2-Methylquinoline-6-methanol

Similarity: 0.85

Chemical Structure| 165111-37-5

[ 165111-37-5 ]

(6-Fluoroquinolin-2-yl)methanol

Similarity: 0.84

Chemical Structure| 4939-28-0

[ 4939-28-0 ]

(2-Methylquinolin-4-yl)methanol

Similarity: 0.81